ALT
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Monday, January 31, 2022 1 min read
Key Takeaway: Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Full Press Release Details
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity.